Managing Type 2 Diabetes Mellitus effectively often requires a combination approach that targets multiple pathways responsible for elevated blood sugar levels. GLIDAPAFLOZIN TRIO 2 FORTE, manufactured and marketed by Steris Healthcare, is a powerful triple-combination antidiabetic formulation containing Dapagliflozin 10 mg, Glimepiride 2 mg, and Metformin 1000 mg. This advanced combination helps patients achieve better glycemic control while reducing the risk of long-term diabetes-related complications.

What is Dapagliflozin 10 Glimepiride 2 Metformin 1000 mg?

GLIDAPAFLOZIN TRIO 2 FORTE is a prescription medicine used for the treatment of Type 2 Diabetes Mellitus in adults when diet, exercise, and monotherapy fail to achieve adequate blood glucose control.

Composition

• Dapagliflozin 10 mg
• Glimepiride 2 mg
• Metformin Hydrochloride 1000 mg

This triple-drug combination provides comprehensive diabetes management by addressing insulin resistance, insulin secretion, and excess glucose reabsorption.

How Dapagliflozin 10 Glimepiride 2 Metformin 1000 Works

The effectiveness of GLIDAPAFLOZIN TRIO 2 FORTE lies in its three complementary mechanisms.

Mechanism of Action

Dapagliflozin 10 mg

Dapagliflozin belongs to the SGLT2 inhibitor class. It blocks the Sodium-Glucose Co-Transporter 2 in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine.

Benefits:

• Lowers blood glucose levels
• Supports weight reduction
• Helps reduce blood pressure
• Provides cardiovascular and renal protection

Glimepiride 2 mg

Glimepiride is a sulfonylurea that stimulates pancreatic beta cells to release more insulin.

Benefits:

• Enhances insulin secretion
• Improves glucose utilization
• Provides rapid reduction in blood sugar levels

Metformin 1000 mg

Metformin is a biguanide that reduces hepatic glucose production and improves insulin sensitivity.

Benefits:

• Decreases liver glucose output
• Improves insulin resistance
• Helps maintain healthy body weight
• Reduces glucose absorption from the intestine

Together, these three ingredients create a synergistic effect that offers superior blood sugar control compared to individual therapies.

Why Dapagliflozin 10 Glimepiride 2 Metformin 1000 Is Important

Type 2 diabetes is a progressive metabolic disorder that affects millions of individuals worldwide. Poorly controlled diabetes can lead to:

• Heart disease
• Stroke
• Kidney damage
• Vision loss
• Neuropathy
• Diabetic foot complications

GLIDAPAFLOZIN TRIO 2 FORTE helps control blood glucose through multiple pathways, making it an effective solution for patients requiring intensified treatment.

INDICATIONS

GLIDAPAFLOZIN TRIO 2 FORTE is indicated for:

• Type 2 Diabetes Mellitus
• Uncontrolled diabetes despite dual therapy
• Patients requiring enhanced glycemic control
• Management of elevated HbA1c levels
• Prevention of diabetes-related complications
• Long-term blood glucose management

Key Benefits of Dapagliflozin 10 Glimepiride 2 Metformin 1000

Comprehensive Triple Action

The formulation attacks diabetes through three distinct mechanisms simultaneously.

Better HbA1c Reduction

Clinical studies suggest triple-combination therapy often achieves superior HbA1c reduction compared to monotherapy or dual therapy.

Supports Weight Management

Unlike some diabetes medicines, dapagliflozin promotes urinary glucose excretion, helping support weight reduction.

Cardiovascular Benefits

Dapagliflozin has demonstrated cardiovascular benefits in suitable patients with Type 2 diabetes.

Kidney Protection

SGLT2 inhibitors are increasingly recognized for their renal protective properties.

Reduced Insulin Resistance

Metformin improves insulin sensitivity, helping the body use insulin more effectively.

Convenient Once-Daily Therapy

Combination therapy improves patient compliance by reducing pill burden.

What Are the Benefits of GLIDAPAFLOZIN TRIO 2 FORTE?

Effective Blood Sugar Control

Maintains fasting and post-meal blood glucose levels.

Improved Glycemic Stability

Helps reduce fluctuations in blood sugar levels throughout the day.

Lower Risk of Long-Term Complications

Consistent glucose control may help prevent:

• Retinopathy
• Nephropathy
• Neuropathy
• Cardiovascular complications

Improved Quality of Life

Patients often experience:

• Better energy levels
• Reduced diabetic symptoms
• Improved overall well-being

Enhanced Treatment Adherence

One tablet containing three proven medicines simplifies diabetes management.

Efficacy and Clinical Evidence

The individual components of GLIDAPAFLOZIN TRIO 2 FORTE have extensive clinical evidence supporting their efficacy.

Dapagliflozin Clinical Benefits

Studies have shown that dapagliflozin:

• Reduces HbA1c significantly
• Promotes weight loss
• Lowers systolic blood pressure
• Provides cardiovascular protection
• Supports kidney health

Glimepiride Clinical Benefits

Research demonstrates that glimepiride:

• Improves insulin release
• Reduces fasting blood glucose
• Lowers HbA1c effectively

Metformin Clinical Benefits

Metformin remains the first-line treatment for Type 2 diabetes because it:

• Improves insulin sensitivity
• Reduces hepatic glucose production
• Supports long-term glycemic control
• Has a favorable safety profile

Side Effects of Dapagliflozin 10 Glimepiride 2 Metformin 1000

Like all medicines, GLIDAPAFLOZIN TRIO 2 FORTE may cause side effects.

Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Increased urination
• Dizziness
• Weakness
• Stomach discomfort
• Urinary tract infections
• Genital fungal infections

Serious Side Effects of Dapagliflozin 10 Glimepiride 2 Metformin 1000

Seek immediate medical attention if you experience:

• Severe hypoglycemia
• Allergic reactions
• Breathing difficulties
• Severe dehydration
• Ketoacidosis
• Lactic acidosis
• Severe kidney problems
• Persistent abdominal pain
• Severe urinary infections

Available Substitute for Dapagliflozin 10 Glimepiride 2 Metformin 1000

Several brands may contain similar combinations, however treatment substitution should only be done under physician supervision.

Patients should consult healthcare professionals before switching medications to ensure dosage equivalence and therapeutic suitability.

Dosage Guidelines for Dapagliflozin 10 Glimepiride 2 Metformin 1000

Recommended Dosage

• Take exactly as prescribed by your doctor.
• Usually administered once daily with meals.
• Swallow the tablet whole with water.
• Do not crush or chew the tablet.

Missed Dose

If a dose is missed:

• Take it as soon as remembered.
• Skip if the next scheduled dose is near.
• Do not double the dose.

Overdose

Seek emergency medical attention in case of overdose.

Symptoms may include:

• Severe hypoglycemia
• Dizziness
• Excessive sweating
• Confusion
• Loss of consciousness

Precautions & Warnings

Kidney Disease

Patients with impaired kidney function require medical evaluation before starting therapy.

Liver Disease

Use cautiously in patients with liver impairment.

Pregnancy

Not recommended during pregnancy unless specifically advised by a healthcare provider.

Breastfeeding

Consult your doctor before use.

Alcohol Consumption

Excessive alcohol intake may increase the risk of lactic acidosis and hypoglycemia.

Elderly Patients

Require careful monitoring due to increased risk of dehydration and hypoglycemia.

Driving and Machinery

Low blood sugar may impair concentration and reaction time.

Why Choose GLIDAPAFLOZIN TRIO 2 FORTE from Steris Healthcare?

Steris Healthcare is committed to delivering high-quality pharmaceutical products that meet stringent manufacturing standards.

Advantages

• Advanced triple-combination therapy
• WHO-GMP compliant manufacturing
• Consistent product quality
• Improved patient compliance
• Reliable therapeutic outcomes
• Trusted healthcare partner

GLIDAPAFLOZIN TRIO 2 FORTE is designed to provide comprehensive diabetes management in a convenient single-tablet formulation.

Conclusion

GLIDAPAFLOZIN TRIO 2 FORTE by Steris Healthcare combines the proven efficacy of Dapagliflozin 10 mg, Glimepiride 2 mg, and Metformin 1000 mg into a single powerful tablet for managing Type 2 Diabetes Mellitus. Through its triple mechanism of action, it effectively lowers blood sugar levels, improves insulin sensitivity, enhances insulin secretion, and supports cardiovascular and renal health.

For patients struggling to achieve glycemic targets with conventional therapy, GLIDAPAFLOZIN TRIO 2 FORTE offers a comprehensive and convenient treatment option that may help improve long-term diabetes outcomes and quality of life.

Frequently Asked Questions 

1. What does this medication do?

GLIDAPAFLOZIN TRIO 2 FORTE lowers blood sugar levels in adults with Type 2 Diabetes Mellitus by improving insulin action, increasing insulin secretion, and removing excess glucose through urine.

2. Are there major side effects?

Most side effects are mild. Serious side effects such as severe hypoglycemia, ketoacidosis, lactic acidosis, and severe infections are uncommon but require immediate medical attention.

3. How do I take it?

Take the tablet exactly as prescribed by your doctor, usually with food and a full glass of water.

4. Where can I get it and what does it cost?

The medication is available through authorized pharmacies and healthcare distributors across India. Pricing may vary by region and supplier.

5. What is dapagliflozin metformin and glimepiride?

It is a triple-combination antidiabetic therapy used for the management of Type 2 Diabetes Mellitus when stronger blood sugar control is required.

6. Can dapagliflozin be used with glimepiride?

Yes. Dapagliflozin and glimepiride are often used together under medical supervision to improve blood glucose control through complementary mechanisms.

7. What is dapagliflozin 10 glimepiride 2 metformin 500 mg?

It is a related diabetes treatment combination containing Dapagliflozin 10 mg, Glimepiride 2 mg, and Metformin 500 mg. The choice between 500 mg and 1000 mg metformin strengths depends on the patient's clinical requirements and physician recommendation.

 

 

Brand Name: GLIDAPAFLOZIN TRIO 2 FORTE (Steris Healthcare Pvt Ltd)

Composition Name: Dapagliflozin 10 mg, Glimepiride 2 mg & Metformin Hydrochloride 1000 mg (Extended Release)

Formulation: Extended-Release Tablet

Pack Size: 4 x 15 Tablets

Marketed By: Steris Healthcare Pvt Ltd

Regulatory Standard: WHO-GMP Certified Manufacturing Facility

Therapeutic Category: Anti-Diabetic Medicine

Indication: Management of Type 2 Diabetes Mellitus

Schedule: Valid Prescription Required (Prescription Only Medicine)

If You Need More Information About  GLIDAPAFLOZIN TRIO 2 FORTE  Click here